# The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation

Study · id `cardio:ct-nct01438580` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01438580](<https://clinicaltrials.gov/study/NCT01438580>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01438580

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 260 participants.

## Technical summary

Registry record NCT01438580. Randomized; single masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2012-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 260 participants (enrolled count; ClinicalTrials.gov record NCT01438580, source copy `cardio:ctgov-nct01438580-2012-05-21`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01438580, source copy `cardio:ctgov-nct01438580-2012-05-21`, retrieved 2026-10-26)
- Primary completion: 2012-01 (actual) (ClinicalTrials.gov record NCT01438580, source copy `cardio:ctgov-nct01438580-2012-05-21`, retrieved 2026-10-26)
- Completion: 2012-04 (actual) (ClinicalTrials.gov record NCT01438580, source copy `cardio:ctgov-nct01438580-2012-05-21`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01438580, source copy `cardio:ctgov-nct01438580-2012-05-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01438580-2012-05-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation
- Condition: Atrial Fibrillation
- Intervention (Drug): Warfarin
- Intervention (Drug): aspirin
- Lead sponsor: Nanjing Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Warfarin (`core:warfarin`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Nanjing Medical University (`cardio:org-nanjing-medical-university`)

## Provenance

Content hash: 7d7c13820a047fef6c56b0b7866d2a104ef96c6d28ece37a8d2359fb64f9da2b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
